Loading asset research
Adial Pharmaceuticals Inc Common Stock
ADILNasdaq · USD · StocksQuote as of · Exchange session not verified$4.90
-18.33%
Today
ADIL
Loading 1D prices…
Market cap
$14.4M
Volume
108.5K
52w high
$10.7552w low
$1.31Company profile
Adial Pharmaceuticals Inc Common Stock
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Glen Allen, VA, United States
Employees
5
Fiscal year end
1231
CIK
1513525
Session & valuation
Open$6.06
Previous close$6.00
Day high$6.11
Day low$4.80
30-day avg. volume74.9K
Outstanding shares2.6M
Diluted EPS-$11.93
Latest annual period
P/E (trailing)-0.41
P/E (forward)-0.66
Price / book-0.34
Beta1.39
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| HINDVyome Holdings Inc. Common Stock | $14.5M | $319.7K | -3209.75% | -$4.86 | -1.90% | Buy |
| SCNXScienture Holdings Inc. Common Stock | $14.3M | $431.6K | -9618.03% | -$2.70 | -2.65% | Buy |
| LSTALisata Therapeutics Inc. Common Stock | $14.7M | $170K | -9756.47% | -$1.91 | -0.61% | Hold |
| MBRXMoleculin Biotech Inc. Common Stock | $13.9M | $0.00 | — | -$28.42 | -12.47% | Buy |
| DAREDare Bioscience Inc. Common Stock | $13.9M | $1M | -1300.73% | -$1.20 | +0.27% | Buy |